VALVULAR AND STRUCTURAL HEART DISEASES Original Studies Efficacy and Safety of Transcatheter Aortic Valve Replacement in Intermediate Surgical Risk Patients: A Systematic Review and Meta-analysis

The efficacy of transcatheter aortic valve replacement (TAVR) in aortic stenosis patients at high surgical risk has been established. The data on patients with intermediate risk is not conclusive. We performed a meta‐analysis of studies which compared TAVR with surgical aortic valve replacement (SAVR) in patients at intermediate surgical risk.

[1]  C. Schmitt,et al.  A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1,141 patients with severe symptomatic aortic stenosis and less than high risk , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  Hongyan Qiao,et al.  2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. , 2015, Journal of the American College of Cardiology.

[3]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[4]  P. Lemos,et al.  Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. , 2015, Journal of the American College of Cardiology.

[5]  F. Santini,et al.  CRT-800 Transfemoral Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Aortic Stenosis at Intermediate Surgical Risk: 12-month Results: from the OBSERVANT Study , 2015 .

[6]  M. Mack,et al.  Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial. , 2014, Journal of the American College of Cardiology.

[7]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[8]  Maurice Buchbinder,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[9]  W. O’Neill,et al.  TRANSCATHETER AORTIC VALVE REPLACEMENT VERSUS SURGICAL AORTIC VALVE REPLACEMENT IN A LOW TO INTERMEDIATE RISK POPULATION , 2014 .

[10]  A. Bogers,et al.  Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. , 2013, Journal of the American College of Cardiology.

[11]  F. Santini,et al.  Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. , 2013, International journal of cardiology.

[12]  R. Marcos,et al.  The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies. , 2013 .

[13]  Robert H. Anderson,et al.  A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. , 2013, JACC. Cardiovascular interventions.

[14]  A. Bogers,et al.  Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. , 2012, The Annals of thoracic surgery.

[15]  O. Alfieri,et al.  Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study. , 2012, American heart journal.

[16]  V. Hjortdal,et al.  A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[17]  Sanjay Kaul,et al.  2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. , 2012, Journal of the American College of Cardiology.

[18]  M. Deutsch,et al.  Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future. , 2012, Journal of the American College of Cardiology.

[19]  P. Jüni,et al.  Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. , 2011, Journal of the American College of Cardiology.

[20]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[21]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[22]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[23]  Jonathan J Shuster,et al.  Rebuttal to Carpenter et al. comments on ‘Fixed vs. random effects meta‐analysis in rare event studies: The rosiglitazone link with myocardial infarction and cardiac death’ , 2008, Statistics in medicine.

[24]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[25]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[26]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[27]  M. Cheitlin,et al.  Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery , 2012 .

[28]  C. Bias.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials , 2011 .